These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 36113782)

  • 21. Patients with PWS and related syndromes display differentially methylated regions involved in neurodevelopmental and nutritional trajectory.
    Salles J; Eddiry S; Lacassagne E; Laurier V; Molinas C; Bieth É; Franchitto N; Salles JP; Tauber M
    Clin Epigenetics; 2021 Aug; 13(1):159. PubMed ID: 34389046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Pivotal Role of Oxytocin's Mechanism of Thermoregulation in Prader-Willi Syndrome, Schaaf-Yang Syndrome, and Autism Spectrum Disorder.
    Camerino C
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome.
    Adhikari A; Copping NA; Onaga B; Pride MC; Coulson RL; Yang M; Yasui DH; LaSalle JM; Silverman JL
    Neurobiol Learn Mem; 2019 Nov; 165():106874. PubMed ID: 29800646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
    Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
    J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher plasma orexin A levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls.
    Manzardo AM; Johnson L; Miller JL; Driscoll DJ; Butler MG
    Am J Med Genet A; 2016 Aug; 170(8):2097-102. PubMed ID: 27214028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher plasma orexin a levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls.
    Manzardo AM; Johnson L; Miller JL; Driscoll DJ; Butler MG
    Am J Med Genet A; 2016 Sep; 170(9):2328-33. PubMed ID: 27518917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review.
    Napolitano L; Barone B; Morra S; Celentano G; La Rocca R; Capece M; Morgera V; Turco C; Caputo VF; Spena G; Romano L; De Luca L; Califano G; Collà Ruvolo C; Mangiapia F; Mirone V; Longo N; Creta M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA; Butler MG; Cataletto ME
    J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of intranasal oxytocin in patients with Prader-Willi syndrome: A systematic review and meta-analysis.
    Shalma NM; Alsharabasy MA; Taha AM; Alsawareah A; Manirambona E; Ahmed SK; Mohamed MR; Taha NA; Abd-ElGawad M
    Diabetes Metab Syndr; 2023 Feb; 17(2):102711. PubMed ID: 36774885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial.
    Kuppens RJ; Donze SH; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):979-987. PubMed ID: 27486141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxytocin in young children with Prader-Willi syndrome: Results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin.
    Damen L; Grootjen LN; Juriaans AF; Donze SH; Huisman TM; Visser JA; Delhanty PJD; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2021 May; 94(5):774-785. PubMed ID: 33296519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Oxytocin a Contributor to Behavioral and Metabolic Features in Prader-Willi Syndrome?
    Petersson M; Höybye C
    Curr Issues Mol Biol; 2024 Aug; 46(8):8767-8779. PubMed ID: 39194735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism.
    Meziane H; Schaller F; Bauer S; Villard C; Matarazzo V; Riet F; Guillon G; Lafitte D; Desarmenien MG; Tauber M; Muscatelli F
    Biol Psychiatry; 2015 Jul; 78(2):85-94. PubMed ID: 25599930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal models for Prader-Willi syndrome.
    Zahova S; Isles AR
    Handb Clin Neurol; 2021; 181():391-404. PubMed ID: 34238473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genes Related to Oxytocin and Arginine-Vasopressin Pathways: Associations with Autism Spectrum Disorders.
    Zhang R; Zhang HF; Han JS; Han SP
    Neurosci Bull; 2017 Apr; 33(2):238-246. PubMed ID: 28283809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.
    Muscogiuri G; Formoso G; Pugliese G; Ruggeri RM; Scarano E; Colao A;
    Rev Endocr Metab Disord; 2019 Jun; 20(2):239-250. PubMed ID: 31065942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteins and proteases of Prader-Willi syndrome: a comprehensive review and perspectives.
    Basak S; Basak A
    Biosci Rep; 2022 Jun; 42(6):. PubMed ID: 35621394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changeability of the fully methylated status of the 15q11.2 region in induced pluripotent stem cells derived from a patient with Prader-Willi syndrome.
    Okuno H; Nakabayashi K; Abe K; Ando T; Sanosaka T; Kohyama J; Akamatsu W; Ohyama M; Takahashi T; Kosaki K; Okano H
    Congenit Anom (Kyoto); 2017 Jul; 57(4):96-103. PubMed ID: 28004416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.